Dr.
MeMed Diagnostics, Israel
Disclosure(s): MeMed: Employee, Stocks/Bonds (Private Company)
Dr. Eran Eden, PhD
Co-founder and CEO, Board of Directors
Eran has been the CEO of MeMed since its inception in 2009, leading it from an idea to a rapidly growing company. He has 15 years of combined business and academic experience pioneering the development of cutting-edge multidisciplinary technologies that synergize data-science & machine learning, molecular biology and clinical applications. Eran co-founded several highly funded international consortia (e.g., Tailored-Treatment and Respiratory-ImmunoDx), the mission of which is to develop, clinically validate and commercialize novel technologies for diagnosing patients with infectious diseases and inflammatory disorders. He holds a B.Sc. in Computer Engineering, B.A. in Biology, and M.Sc. in Computer Science (all Cum Laude) from the Technion, Israel Institute of Technology, and a Ph.D. in Systems Biology from the Weizmann Institute of Science, where he was also a lecturer of Data Mining. Eran is co-author of over 90 granted patents and pending applications and over 20 peer-reviewed publications and is the recipient of multiple awards including the prestigious GE and Science Prize for Promising Life Scientists.